Skip to main content
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · IEX Real-Time Price · USD
1.080
+0.060 (5.88%)
At close: Jul 2, 2024, 4:00 PM
1.100
+0.020 (1.85%)
After-hours: Jul 2, 2024, 7:57 PM EDT

Cue Biopharma Revenue

Cue Biopharma had revenue of $7.02M in the twelve months ending March 31, 2024, with 1,525.00% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.72M with 818.18% year-over-year growth. In the year 2023, Cue Biopharma had annual revenue of $5.49M with 340.96% growth.

Revenue (ttm)
$7.02M
Revenue Growth
+1,525.00%
P/S Ratio
7.48
Revenue / Employee
$132,453
Employees
53
Market Cap
52.53M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.01K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Personalis 74.15M
HOOKIPA Pharma 53.55M
Cryo-Cell International 31.37M
Turnstone Biologics 19.31M
Hyperfine 11.69M
CollPlant Biotechnologies 10.62M
InspireMD 6.48M
Nutriband 2.02M
Revenue Rankings

CUE News

More News